Researchers using synthetic bacteria to cure disease

The video discusses PKU, a condition where individuals cannot break down phenylalanine, necessitating dietary restrictions. Researchers at Synlogic have developed a genetically engineered probiotic, Sin B 1618, to help treat PKU. The treatment involves a two-step process: controlling blood PHE levels and gradually reintroducing natural protein into the diet.

What is the significance of controlling blood PH in the treatment process?

How does the treatment plan change after the initial control of blood PH?